Global Spasticity Treatment Market 2025-2029

Spasticity Treatment Market 2025-2029

The spasticity treatment market is forecasted to grow by USD 1268.6 million during 2024-2029, accelerating at a CAGR of 4.3% during the forecast period. The report on the spasticity treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing incidence of chronic diseases and health conditions, availability of advanced technologies for drug delivery, and introduction of botulinum toxins and cannabinoids.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's spasticity treatment market is segmented as below:

By Type

• Drug therapy
• Physical therapy
• Surgical treatment

By End-user

• Hospitals
• Ambulatory surgical centers
• Home care settings
• Specialty clinics
• Diagnostic centers

By Indication

• Cerebral palsy
• Multiple sclerosis
• Traumatic brain injury
• Others

By Route Of Administration

• Oral
• Parenteral

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the advent of neurostimulation devices for spasticity treatment as one of the prime reasons driving the spasticity treatment market growth during the next few years. Also, growing awareness of spasticity and telemedicine and remote monitoring for spasticity treatment will lead to sizable demand in the market.

The report on the spasticity treatment market covers the following areas:

• Spasticity Treatment Market sizing
• Spasticity Treatment Market forecast
• Spasticity Treatment Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading spasticity treatment market vendors that include Abbott Laboratories, Axonics Inc., BioWave Ltd., Boston Scientific Corp., BrainsWay Ltd., electroCore Inc., LivaNova PLC, Mayo Foundation for Medical Education and Research, Medtronic PLC, NEURONETICS Inc., Nevro Corp., OMRON Corp., PathMaker Neurosystems Inc., Rady Children's Hospital–SAN Diego, Saebo, Saluda Medical Pty Ltd., ShiraTronics, The Johns Hopkins Health System Corp., Theranica Bio Electronics Ltd., and Thync Global Inc.. Also, the spasticity treatment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.